Claire Hara-Cleaver

Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis

Myles Horton, Richard A. Rudick, Claire Hara-Cleaver et al. · Neuroepidemiology · 2010 · 163 citations

Medicine, Neurology, Behavioral Health +16

Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic

Ebru Erbayat Altay, Elizabeth Fisher, Stephen E. Jones et al. · JAMA Neurology · 2012 · 94 citations · Full text

Medicine, Neurology, Radiology +13

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS

J. A. Cohen, Peter B. Imrey, Peter A. Calabresi et al. · Neurology · 2009 · 82 citations

Life Sciences, Neurology, Pharmacotherapy +16

Early tolerability and safety of fingolimod in clinical practice

Daniel Ontaneda, Claire Hara-Cleaver, Richard A. Rudick et al. · Journal of the Neurological Sciences · 2012 · 52 citations

Pharmacy, Pharmacotherapy, Pharmacovigilance +4

Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up

Carrie M. Hersh, Thomas E. Love, Samuel Cohn et al. · Multiple Sclerosis and Related Disorders · 2016 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8